Tuning innate immune function using microneedles containing multiple classes of toll-like receptor agonists

Microneedle arrays (MNAs) are patches displaying hundreds of micron-scale needles that can penetrate skin. As a result, these arrays efficiently and painlessly access this immune cell-rich niche, motivating significant clinical interest in MNA-based vaccines. Our lab has developed immune polyelectrolyte multilayers (iPEMs), nanostructures built entirely from immune signals employing electrostatic self-assembly. iPEMs consist of positively charged peptide antigen and negatively charged toll-like receptor agonists (TLRas) to assemble these components at ultra-high density since no carrier is needed. Here we used this technology to deliver MNAs with antigen and defined ratios of multiple classes of TLRa. Notably, this approach resulted in facile assembly and corresponding signal transduction through each respective TLR pathway. This control ultimately activated primary antigen presenting cells and drove proliferation of antigen-specific T cells. In related in vivo vaccine studies, application of MNAs resulted in distinct T cells response depending on the number of TLRa classes delivered with MNAs. These MNAs technologies create an opportunity to deliver nanostructured vaccine components at high density, and to probe integration of multiple TLRas in skin to tune immunity.

Automated summary

Microneedle arrays (MNAs) are patches with micron-scale needles that can penetrate skin, allowing efficient and painless access to immune cell-rich areas. By utilizing immune polyelectrolyte multilayers (iPEMs), nanostructures made from immune signals using electrostatic self-assembly, MNAs can deliver antigen and toll-like receptor agonists (TLRas) in defined ratios. This approach activates antigen presenting cells and antigen-specific T cells, leading to different T cell responses depending on the number of TLRa classes delivered with MNAs. These MNAs technologies provide a way to deliver nanostructured vaccine components at high density and investigate the integration of multiple TLRas in skin to modulate immunity.